Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy

Matthias Helmschrott,1 Rasmus Rivinius,1 Thomas Bruckner,2 Hugo A Katus,1 Andreas O Doesch1 1Department of Cardiology, Angiology, Pneumology, 2Institute for Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany Background: A calcineurin inhibitor (CNI)-based immunosuppres...

Full description

Bibliographic Details
Main Authors: Helmschrott M, Rivinius R, Bruckner T, Katus HA, Doesch AO
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Drug Design, Development and Therapy
Subjects:
heart transplantation
cyclosporine A
tacrolimus
risk factors
Online Access:https://www.dovepress.com/renal-function-in-heart-transplant-patients-after-switch-to-combined-m-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/renal-function-in-heart-transplant-patients-after-switch-to-combined-m-peer-reviewed-article-DDDT

Similar Items